Sanofi and Teva Pharmaceuticals, a U.S. subsidiary of Teva Pharmaceutical Industries Ltd., announce today a collaboration to co-develop and co-commercialize asset TEV’574, currently in Phase 2b clinical trials for the treatment of Ulcerative Colitis and Crohn’s Disease, two types of…
Sandoz, the global leader in generic and biosimilar medicines, today celebrates the start of share trading on the SIX Swiss Exchange as an independent company. The new company is included in key SIX market indices and has an investment-grade credit…
Today Allergan Aesthetics, an AbbVie company, announces its fifth year of partnership with Girls Inc., this year supporting Project Accelerate, a program addressing inequality in the workplace that aims to accelerate young women’s trajectories through college and career entry. The…
Gilead Sciences, announced that Kevin E Lofton, Lead Independent Director, has been named one of the most influential leaders in corporate governance by the NACD (National Association of Corporate Directors) as part of their 2023 NACD Directorship 100™, an annual…
Novartis today announced positive top-line results from the pre-specified interim analysis of the Phase III APPLAUSE-IgAN study at 9 months. Iptacopan, an investigational factor B inhibitor targeting the alternative complement pathway, demonstrated superiority versus placebo in proteinuria (protein in urine)…
The Nobel Assembly at Karolinska Institutet has today decided to award the 2023 The Nobel Prize in Physiology or Medicine jointly to Katalin Karikó and Drew Weissman for their discoveries concerning nucleoside base modifications that enabled the development of effective…
Each October serves as a reminder of the profound and constructive influence that a diverse community of individuals can have on society as a whole. It is our differences that make us unique.
For more than 30 years, The Estée Lauder Companies’ Breast Cancer Campaign (The Campaign) has been dedicated to advancing the possibility of a breast cancer-free world for all. This October, The Estée Lauder Companies (ELC) honors Breast Cancer Awareness Month…
Sernova, a clinical-stage company and leader in Cell Therapeutics, announced new preclinical data for its novel cell therapy platform, the Cell Pouch System, as a potential treatment for post-operative hypothyroidism at the 2023 American Thyroid Association, Inc. (ATA) Annual Meeting…
Bagsværd, Denmark and Boston, Massachusetts, US, 25 September 2023 – Novo Nordisk A/S and Valo Health, Inc. today announced they have entered into an agreement to discover and develop novel treatments for cardiometabolic diseases based on Valo’s large human dataset and computation…